Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Elise Olsen, Eric Vonderheid, Nicola Pimpinelli, Rein Willemze, Youn Kim, Robert Knobler, Herschel Zackheim, Madeleine Duvic, Teresa Estrach, Stanford I. Lamberg, Gary Wood, Reinhard Dummer, Annamari Ranki, Gunter Burg, Peter Heald, Mark Pittelkow, Maria Grazia Bernengo, Wolfram Sterry, Liliane Laroche, Franz TrautingerSean Whittaker

Research output: Contribution to journalArticle

Abstract

The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and Sézary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.

Original languageEnglish (US)
Pages (from-to)1713-1722
Number of pages10
JournalBlood
Volume110
Issue number6
DOIs
StatePublished - Sep 15 2007

Fingerprint

Cytology
Mycosis Fungoides
T-cells
Advisory Committees
Tumors
Lymphoma
Organizations
Skin
Communication
Research
Neoplasms
Cutaneous T-Cell Lymphoma
Therapeutics
Cell Biology
Publications
Clinical Trials
Guidelines

ASJC Scopus subject areas

  • Hematology

Cite this

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome : A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). / Olsen, Elise; Vonderheid, Eric; Pimpinelli, Nicola; Willemze, Rein; Kim, Youn; Knobler, Robert; Zackheim, Herschel; Duvic, Madeleine; Estrach, Teresa; Lamberg, Stanford I.; Wood, Gary; Dummer, Reinhard; Ranki, Annamari; Burg, Gunter; Heald, Peter; Pittelkow, Mark; Bernengo, Maria Grazia; Sterry, Wolfram; Laroche, Liliane; Trautinger, Franz; Whittaker, Sean.

In: Blood, Vol. 110, No. 6, 15.09.2007, p. 1713-1722.

Research output: Contribution to journalArticle

Olsen, E, Vonderheid, E, Pimpinelli, N, Willemze, R, Kim, Y, Knobler, R, Zackheim, H, Duvic, M, Estrach, T, Lamberg, SI, Wood, G, Dummer, R, Ranki, A, Burg, G, Heald, P, Pittelkow, M, Bernengo, MG, Sterry, W, Laroche, L, Trautinger, F & Whittaker, S 2007, 'Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)', Blood, vol. 110, no. 6, pp. 1713-1722. https://doi.org/10.1182/blood-2007-03-055749
Olsen, Elise ; Vonderheid, Eric ; Pimpinelli, Nicola ; Willemze, Rein ; Kim, Youn ; Knobler, Robert ; Zackheim, Herschel ; Duvic, Madeleine ; Estrach, Teresa ; Lamberg, Stanford I. ; Wood, Gary ; Dummer, Reinhard ; Ranki, Annamari ; Burg, Gunter ; Heald, Peter ; Pittelkow, Mark ; Bernengo, Maria Grazia ; Sterry, Wolfram ; Laroche, Liliane ; Trautinger, Franz ; Whittaker, Sean. / Revisions to the staging and classification of mycosis fungoides and Sézary syndrome : A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). In: Blood. 2007 ; Vol. 110, No. 6. pp. 1713-1722.
@article{ef9de79ad6fe407090c036fb9be2dc85,
title = "Revisions to the staging and classification of mycosis fungoides and S{\'e}zary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)",
abstract = "The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and S{\'e}zary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.",
author = "Elise Olsen and Eric Vonderheid and Nicola Pimpinelli and Rein Willemze and Youn Kim and Robert Knobler and Herschel Zackheim and Madeleine Duvic and Teresa Estrach and Lamberg, {Stanford I.} and Gary Wood and Reinhard Dummer and Annamari Ranki and Gunter Burg and Peter Heald and Mark Pittelkow and Bernengo, {Maria Grazia} and Wolfram Sterry and Liliane Laroche and Franz Trautinger and Sean Whittaker",
year = "2007",
month = "9",
day = "15",
doi = "10.1182/blood-2007-03-055749",
language = "English (US)",
volume = "110",
pages = "1713--1722",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - Revisions to the staging and classification of mycosis fungoides and Sézary syndrome

T2 - A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

AU - Olsen, Elise

AU - Vonderheid, Eric

AU - Pimpinelli, Nicola

AU - Willemze, Rein

AU - Kim, Youn

AU - Knobler, Robert

AU - Zackheim, Herschel

AU - Duvic, Madeleine

AU - Estrach, Teresa

AU - Lamberg, Stanford I.

AU - Wood, Gary

AU - Dummer, Reinhard

AU - Ranki, Annamari

AU - Burg, Gunter

AU - Heald, Peter

AU - Pittelkow, Mark

AU - Bernengo, Maria Grazia

AU - Sterry, Wolfram

AU - Laroche, Liliane

AU - Trautinger, Franz

AU - Whittaker, Sean

PY - 2007/9/15

Y1 - 2007/9/15

N2 - The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and Sézary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.

AB - The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and Sézary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.

UR - http://www.scopus.com/inward/record.url?scp=34548849451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548849451&partnerID=8YFLogxK

U2 - 10.1182/blood-2007-03-055749

DO - 10.1182/blood-2007-03-055749

M3 - Article

C2 - 17540844

AN - SCOPUS:34548849451

VL - 110

SP - 1713

EP - 1722

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -